Media & Funding

Welcome to UCB's media room. This section offers resources for journalists, editors and other media professionals.

Coming soon

02/03/2024

ZILBRYSQ^® (zilucoplan injection)

Now Approved for Adults with Generalized Myasthenia Gravis (gMG) in Canada

07/16/2024

BIMZELX^® (bimekizumab)

Now Approved for Adults with Active Psoriatic Arthritis and for Adults with Axial Spondyloarthritis

If you are a member of the media and require further information about UCB Canada Inc. or its products, please contact: mediacanada@ucb.com.